Inovio Investors Get Derivative Deal OK'd Over Vaccine Claims
By Emilie Ruscoe · June 15, 2023, 9:12 PM EDT
Investors in biotechnology firm Inovio Pharmaceuticals Inc. have received an initial green light from a Philadelphia federal judge for their agreement to settle their derivative action against the company's brass over...
To view the full article, register now.